European Archives - Page 944 of 1021 - European Medical Journal

EMJ

The Conquer Cancer Foundation of the American Society of Clinical Oncology

At the 2015 American Society of Clinical Oncology (ASCO) Annual Meeting, Julie M. Vose, MD, MBA, FASCO, of the University of Nebraska Medical Center…

EMJ

Evaluating sustained adherence to ibrutinib in previously treated CLL

At the 2015 American Society of Clinical Oncology (ASCO) Annual Meeting, Jacqueline Barrientos, MD, of North Shore-LIJ Cancer Institute, Lake Success…

EMJ

New Surgical Method Preserves Kidney Function After Tumour Removal

SURGICAL technique that preserves long-term renal function by treating complex renal tumours has been performed successfully for the first time…

EMJ

Long-Term Survival Rates Sufficient for Bladder Cancer Patients Treated With Robotic Surgery

PATIENTS diagnosed with bladder cancer (BLC) and treated with robot-assisted surgery experience similar results to those who undergo a traditional open…

EMJ

A Blue-ming Good Way of Promoting Men’s Health

Proudly supported by The Urology Foundation, Blue September is a fun way of delivering a serious message about ‘facing up to cancer in men’.

EMJ

Therapy for newly diagnosed patients with mantle cell lymphoma

At the 20th Congress of the European Hematology Association (EHA), Marek Trněný, MD, PhD, of Charles University, Prague, Czech Republic, discusses new…

EMJ

Introducing biomarkers for the management of patients with prostate cancer

At the 2015 American Society of Clinical Oncology (ASCO) Annual Meeting, Eleni Efstathiou, MD, PhD, of The University of Texas MD Anderson Cancer Center…

EMJ

CALGB 49907 trial: Standard chemotherapy versus capecitabine for older women with breast cancer

At the 2015 American Society of Clinical Oncology (ASCO) Annual Meeting, Hyman Muss, MD, of the University of North Carolina, Chapel Hill, NC, provides…

EMJ

Developing targeted therapies for melanoma

At the 2015 American Society of Clinical Oncology (ASCO) Annual Meeting, Georgina Long, BSc, PhD, MBBS, FRACP, of the University of Sydney, Sydney…

EMJ

European Medicines Agency Validates Gilead’s Marketing Application for Single Tablet Regimen Containing Rilpivirine, Emtricitabine and Tenofovir Alafenamide (R/F/TAF) for HIV Treatment

Foster City, CA, August 20, 2015 – Gilead Sciences, Inc. (NASDAQ: GILD) today announced that the company’s Marketing Authorization Application (MAA)…